Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | 0 | reported | 18 Nov 2024 | tx 24+889,166−203,332 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2024 | SALE | Syros Pharmaceuticals, Inc. | 134,797 | 0.20 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | — | |
| 31 Oct 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 8,707 | 2.09 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 10 Sept 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 50,000 | 1.51 USD | |
| 11 Sept 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 50,000 | 1.71 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11,666 | — | |
| 01 Apr 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 3,500 | 5.12 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11,666 | 0.00 USD | deriv |
| 02 Dec 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 86,000 | 0.00 USD | deriv |
| 01 Nov 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6,004 | 2.22 USD | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | — | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 03 Apr 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 658 | 2.58 USD | |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 80,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 27 Sept 2021 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 360,000 | 0.00 USD | deriv |